Ajanta Pharma Ltd. FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection VAI · Apr 21, 2026
  • No warning letters matched by name
Inspections 9 0 OAI
Recalls 3 0 Class I (0%)
Warning letters 0 None on file
510(k) clearances 0 None on file

Ajanta Pharma Ltd. has 3 FDA recalls, 9 inspections, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Ajanta Pharma Ltd." is on file.

What these totals cover: FDA records filed under the name "Ajanta Pharma Ltd." and its spelling variants "Ajanta Pharma", "Ajanta Pharma Limited".

Latest recall
D-0514-2026 · Class II · Apr 29, 2026
Latest inspection
Apr 21, 2026 · VAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls3Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections9Nov 17, 2026Newest record Nov 9, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Ajanta Pharma Ltd.'s FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Ajanta Pharma Ltd.: FDA inspections per year

2017: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 2 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 1 inspection (0 OAI), 0 warning letters, 3 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202610030
202500000
202410000
202310000
202200000
202100000
202000000
201920000
201810000
201710000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Ajanta Pharma Ltd. as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Ajanta Pharma Ltd. yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Recent recalls

3 recall records on Apr 29, 2026.

NumberClassProductDate
D-0514-2026Class IIDuloxetine Delayed-Release Capsules, 30 mg, Rx Only, a) 90 Capsules, NDC 27241-098-09, b) 30…Apr 29, 2026
D-0516-2026Class IIDuloxetine Delayed-Release Capsules, 20 mg, Rx Only, 60 capsules, Marketed by: Ajanta Pharma USA…Apr 29, 2026
D-0515-2026Class IIDuloxetine Delayed-Release Capsules, 60 mg, Rx Only, 30 capsules, Marketed by: Ajanta Pharma USA…Apr 29, 2026

Recent FDA inspections

9 inspections from Sep 6, 2012 to Apr 21, 2026.

DateSiteProductClassificationFEI
Apr 21, 2026Paithan, IndiaDrugsVoluntary Action Indicated (VAI)3006785788
Mar 5, 2024Paithan, IndiaDrugsNo Action Indicated (NAI)3006785788
Jun 23, 2023Bharuch, IndiaDrugsNo Action Indicated (NAI)3012664809
Jun 28, 2019Paithan, IndiaDrugsVoluntary Action Indicated (VAI)3006785788
Jun 22, 2019Bharuch, IndiaDrugsVoluntary Action Indicated (VAI)3012664809
Feb 9, 2018Bharuch, IndiaDrugsNo Action Indicated (NAI)3012664809
Feb 7, 2017Paithan, IndiaDrugsVoluntary Action Indicated (VAI)3006785788
Mar 20, 2015Paithan, IndiaDrugsVoluntary Action Indicated (VAI)3006785788
Sep 6, 2012Paithan, IndiaDrugsVoluntary Action Indicated (VAI)3006785788
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

2 inspected sites, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3006785788Paithan, India6Apr 21, 2026
FEI 3012664809Bharuch, India3Jun 23, 2023

Ajanta Pharma Ltd. and the FDA: common questions

Has Ajanta Pharma Ltd. received an FDA warning letter?

No FDA warning letter addressed to the name "Ajanta Pharma Ltd." is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Ajanta Pharma Ltd. received an FDA Form 483?

FDA has not published a Form 483 for "Ajanta Pharma Ltd." in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Ajanta Pharma Ltd.?

The most recent FDA inspection on file ended Apr 21, 2026 at Paithan, India and was classified VAI. FDA has 9 inspections of Ajanta Pharma Ltd. on file.

Has Ajanta Pharma Ltd. had an FDA recall?

Yes. Ajanta Pharma Ltd. has 3 FDA recalls on record. The most recent started Apr 29, 2026.

Need more than this page shows? Ask about Ajanta Pharma Ltd. in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.